Praj Industries Opens AI Bio-Lab, Boosting India's Bioeconomy

INDUSTRIAL-GOODSSERVICES
Whalesbook Logo
AuthorIshaan Verma|Published at:
Praj Industries Opens AI Bio-Lab, Boosting India's Bioeconomy
Overview

Praj Industries has opened an advanced, AI-powered precision fermentation lab at its Pune R&D center. This facility will improve biomanufacturing efficiency and lower risks when scaling up processes for industries like pharmaceuticals, food, and biofuels. A new agreement with BRIC-NCCS also supports India's BioE3 Initiative, speeding up innovation and training in the bioeconomy.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Advanced Biomanufacturing Hub

Praj Industries has launched a cutting-edge, AI-powered precision fermentation laboratory at its Praj Matrix R&D center in Pune. The facility is designed to boost high-capacity bioprocesses, aiming to significantly improve efficiency, reduce scale-up risks, and increase overall process reliability. This lab will help Praj Industries and its subsidiary, Praj HiPurity Systems, provide advanced fermentation solutions for key sectors such as pharmaceuticals, food, cosmetics, biofuels, and beverages.

Praj HiPurity Systems is known for its specialized precision fermenters and ultra-pure water systems, crucial for the pharmaceutical and biotech industries. Integrating AI into these processes marks a major advance in optimizing bioreactor performance and product yield.

Strategic Academia-Industry Alliance

Alongside the lab's launch, Praj Industries has signed a Memorandum of Understanding (MoU) with the Biotechnology Research and Innovation Council – National Centre for Cell Science (BRIC-NCCS). This partnership supports the Indian government's BioE3 Initiative (Biotechnology for Economy, Environment, and Employment), which is managed by the Department of Biotechnology (DBT).

Rajesh S. Gokhale, Secretary of the DBT, highlighted how crucial partnerships between academia and industry are for advancing India's bioeconomy. He noted that such initiatives are essential for promoting research that moves from the lab to practical application and for building national expertise in biotechnology, thereby speeding up innovation and strengthening the country's bio-based economy.

Driving Decarbonization and Innovation

Pramod Chaudhari, founder and chairman of Praj Industries, called the lab a significant step in the company's innovation path. He explained that it combines biology, engineering, and digital technologies to create scalable, low-carbon solutions. Together with the BRIC-NCCS partnership, this work will speed up the shift from laboratory discovery to commercial biomanufacturing.

The facility is intended as a model for future collaborations between academia and industry. It will concentrate on developing advanced bioprocessing skills, discovering new biomolecules and microbial strains, offering practical training for PhD students, and encouraging joint research projects. BRIC-NCCS will bring its expertise in microbial research, genomics, and cell culture collections, creating strong teamwork with Praj's process development and high-purity manufacturing skills.

Praj Matrix, Praj Industries' innovation hub, holds more than 300 national and international patents. Its existing technologies in biofuels, biopolymers, and biobitumen have already made significant contributions to decarbonization efforts, showing the company's dedication to sustainable solutions used worldwide.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.